Clinical Trial Update: Treatment of ppROM With Erythromycin vs. Azithromycin Trial [Phase 3]

View source ↗

Summary

Phase 3 trial comparing erythromycin and azithromycin for preterm premature rupture of membranes has been terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Premature Rupture of Membranes

Drugs mentioned

• Azithromycin (azithromycin)
• ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Preterm Premature Rupture of Membranes (PPROM) | Phase 3 | Status: TERMINATED | Results posted: 2024-06-25